Persistence of tungsten oxide particle/fiber mixtures in artificial human lung fluids
© Stefaniak. 2010
Received: 23 September 2010
Accepted: 2 December 2010
Published: 2 December 2010
During the manufacture of tungsten metal for non-sag wire, tungsten oxide powders are produced as intermediates and can be in the form of tungsten trioxide (WO3) or tungsten blue oxides (TBOs). TBOs contain fiber-shaped tungsten sub-oxide particles of respirable or thoracic size. The aim of this research was to investigate whether fiber-containing TBOs had prolonged biodurability in artificial lung fluids compared to tungsten metal or WO3 and therefore potentially could pose a greater inhalation hazard.
Dissolution of tungsten metal, WO3, one fiber-free TBO (WO2.98), and three fiber-containing TBO (WO2.81, WO2.66, and WO2.51) powders were measured for the material as-received, dispersed, and mixed with metallic cobalt. Solubility was evaluated using artificial airway epithelial lining fluid (SUF) and macrophage phagolysosomal simulant fluid (PSF).
Dissolution rates of tungsten compounds were one to four orders of magnitude slower in PSF compared to SUF. The state of the fiber-containing TBOs did not influence their dissolution in either SUF or PSF. In SUF, fiber-containing WO2.66 and WO2.51 dissolved more slowly than tungsten metal or WO3. In PSF, all three fiber-containing TBOs dissolved more slowly than tungsten metal.
Fiber-containing TBO powders dissolved more slowly than tungsten metal and WO3 powders in SUF and more slowly than tungsten metal in PSF. Existing pulmonary toxicological information on tungsten compounds indicates potential for pulmonary irritation and possibly fibrosis. Additional research is needed to fully understand the hazard potential of TBOs.
Tungsten is a naturally occurring element that has industrial value in the form of its metal, oxide, and salts. One estimate suggests that up to 800,000 workers may be exposed to tungsten compounds in the United States . One common application of tungsten metal is non-sag wire for light bulb filaments . The production of non-sag wire involves calcination of ammonium paratungstate to yield tungsten oxide powder intermediates which are subsequently reduced under controlled conditions to yield tungsten metal powder for making wire filaments. The type of tungsten oxide intermediate produced depends on the calcination conditions, including furnace atmosphere. Yellow tungsten trioxide (WO3) is produced if sufficient air is supplied whereas tungsten blue oxides (TBOs) having varying chemical and physical properties are produced under non-equilibrium conditions when air is excluded. TBO is not a well-defined compound; rather, it is a blue-colored mixture of crystalline hexagonal tungsten bronzes, WO3, and various non-stoichiometric tungsten sub-oxides and an amorphous oxide [2, 3].
During production of TBOs, aerosols are generated which contain tungsten sub-oxides with fiber-shaped morphology. In a Swedish tungsten refining and manufacturing facility, airborne tungsten oxide fibers had respirable size, length (L) ≥ 5 μm, diameter (D) ≤ 3 μm, and aspect ratio = L/D (AR) ≥ 5:1; the physical diameter of most fibers was ≤0.3 μm . Both single fibers and aggregates of fibers were observed in Swedish workplace atmospheres [4–6]. In the United States, greater than 95% of airborne tungsten-containing fibers collected during tungsten refining and manufacturing and hard metal production had thoracic size (i.e., aerodynamic diameter (Dae) ≤ 10 μm) [1, 7].
The toxicity of fibers is influenced by their dimension, durability, and dose (at the target tissue). Fiber dimensions determine the extent to which fibers are inhaled, retained, and cleared by the lung. In humans engaged in mouth breathing, deposition in the alveolar region of the lung is maximal for fibers having Dae of 2 μm and AR of 3 to 20. Biopersistence is determined by the rate at which fibers are physically cleared from the lung by mechanical action (macrophage- or mucocilliary-mediated) and the rate at which they are dissolved (i.e., biodurability) in lung fluids [8, 9]. Fibers longer than 20 μm that deposit on the surface of conducting airways are cleared by mechanical (i.e., mucociliary) action. Because fibers longer than 20 μm that deposit in the unciliated terminal bronchioles or alveoli are not cleared from their deposition site by mucociliary action and probably cannot be engulfed and cleared by a single macrophage, they will likely remain in the lung if biodurable. Engulfment by macrophages of fibers with length between 5 and 20 μm may inhibit macrophage mobility in a graded fashion. Mechanical clearance of fibers shorter than 5 μm by lung alveolar macrophages is probably not influenced by fiber length [8, 9]. Fiber chemistry, in part, determines biodurability, as does the lung fluid pH [8, 9].
Keith et al. , in a U.S. Agency for Toxic Substances and Disease Registry (ATSDR) literature review, has reported the health effects from inhalation of tungsten compounds which has focused almost exclusively on non-fibrous forms. In one study, rats that inhaled tungsten carbide or were intratracheally instilled with tungsten metal or WO3 developed mild pulmonary fibrosis ; another rat intratrachial instillation study reported that WO3 did not affect release of biomarkers linked to fibrosis . Aamodt  exposed beagle dogs by nose-only inhalation to WO3 particles and determined that 33% of the lung-deposited dose entered the systemic circulation, either via dissolution of particles in lung fluid or translocation to the systemic circulation by alveolar macrophages. In some workers exposed to mixed dusts containing tungsten, the tungsten-containing particles that deposit in the alveolar region of the lung persist for years . Workers in the cemented tungsten carbide industry can be exposed to several tungsten compounds, including the metal, carbide, and tungstenate which vary in their solubility in the body . Only one study investigated tungsten oxide fibers. In this in vitro study, laboratory-prepared tungsten oxide fibers, intended to mimic TBO materials, were observed to generate free radicals which could potentially contribute to development of pulmonary fibrosis . Thus, the potential for adverse health effects following inhalation of fiber-shaped tungsten oxide particles is not understood. Given the role of fiber-shaped particles in lung toxicity we investigated whether fiber-containing TBOs are more durable in artificial lung fluids than tungsten metal or WO3 and therefore potentially could pose a greater inhalation hazard.
Materials and methods
The objective of this study was to evaluate whether TBO fibers had prolonged biodurability in artificial lung fluids compared to tungsten metal or WO3. Hence, the dissolution of each tungsten oxide powder was measured in the "as-received" (aggregated), "dispersed" (individual particles), and mechanically mixed (with cobalt) states using two different artificial lung fluids. Dissolution of a pure fine tungsten metal and a fine cobalt metal obtained from a hard metal producer  were also measured to benchmark durability of the tungsten oxides.
Fibers may induce different pathological effects for aggregated and dispersed forms of the same material. Shvedova et al.  reported that aggregated single-walled carbon nanotubes (SWCNT) were associated with induction of granulomas in mouse lung (dosing by pharyngeal aspiration), but dispersed SWCNT were associated with diffuse interstitial fibrosis and alveolar wall thickening. McKernan et al.  detected tungsten-containing fibers in a hard metal production facility, indicating potential for exposure to these airborne fibers beyond the intermediate stages of tungsten metal production. The presence of cobalt is known to enhance the toxicity of tungsten carbide by generating larger amounts of free radicals than equivalent masses of cobalt or tungsten carbide alone . Thus, we measured dissolution for each aggregated powder mixed with cobalt at a ratio of 95:5 by weight. These admixtures do not represent any specific industrial powder formulations but were created to understand the co-dissolution of tungsten in the presence of cobalt.
Five bulk tungsten oxide powders were provided for study by an industrial producer of non-sag tungsten metal wire: yellow WO3 and the TBOs WO2.98, WO2.81, WO2.66, and WO2.51. The only defined tungsten oxide is WO3; the TBOs were manufactured under non-equilibrium conditions and the oxidative states of these powders are average values. The WO2.98 is crystallographically WO3, but has oxygen defects that impart a blue-color to the material. WO2.81 is a mixture of WO2.90 and WO2.72, whereas both WO2.66 and WO2.51 are mixtures of varying proportions of WO2.72 and WO2. The WO3 and WO2.98 powders were examined microscopically as described below and consisted of isometric-shaped particles and accounted for approximately 80% of this manufacturer's production. The WO2.81, WO2.66, and WO2.51 powders were examined microscopically and were mixtures of isometric and fiber particle morphologies and accounted for the remaining 20% of industrial production.
Study powder characterization
The U.S. National Institute for Occupational Safety and Health (NIOSH) Method 7400 with "B" counting rules was used to count tungsten-containing fibers, i.e., L > 5 μm, D < 3 μm, and AR of ≥5:1 [1, 7]. The relative mass fractions of isometric- and fiber-shaped particles in each powder was calculated from measures of 150 to 300 particle external dimensions in 27 to 50 microscope fields per material and the measured density. The orientation-averaged fiber Dae was calculated as described by Griffiths and Vaughn . For isometric-shaped particles, Dae was calculated assuming a dynamic shape factor (χ) of 1.08 for cube-shaped WO3 and WO2.98 particles and χ of 1.00 for spherical tungsten and cobalt particles .
Total C, H, and N impurity content [23, 24] and S impurity content  of powders were determined by combustion by a commercial laboratory (Galbraith Laboratories, Knoxville, TN). Oxygen content was assayed by pyrolysis (LECO Corp, St. Joseph, MI). Inductively coupled plasma (ICP)-atomic emission spectroscopy was used to quantify metal impurities in accordance with NIOSH Method 7303: Elements by ICP . X-ray photoelectron spectroscopy was used to evaluate powder surface (top 20 Å) chemistry (McCrone Associates, Westmont, IL).
Artificial Lung Fluid Dissolution Studies
Dissolution of triplicate samples of each powder was evaluated using a static technique . Known masses (in the range 10 to 100 mg) of each study powder were determined gravimetrically using a calibrated five-place balance (Model AX 205, Mettler Toledo, Greifensee, Switzerland) capable of reading to 10 μg. Each static dissolution chamber was placed in a separate polypropylene cup, immersed in 80 mL of artificial lung fluid, covered with a lid having two holes to allow gas exchange, and maintained at 37 °C throughout an experiment.
Serum ultrafiltrate (SUF) was used to model dissolution in lung airway epithelial lining fluid . This solvent consists of chloride (217.5 mM), sodium (145.7 mM), ammonium (100.0 mM), calcium (29.4 mM), bicarbonate (27.0 mM), cysteine (1.1 mM), phosphate (1.0 mM). sulfate (0.6 mM), citrate (0.2 mM), and diethylenetriaminepentaacetic acid (2 mM), the latter to prevent formation of insoluble phosphate precipitates. The pH of SUF was maintained at 7.4 ± 0.1 by blanketing the headspace in each sample with 5% CO2 and 95% air. Masses of dissolved tungsten were measured after 1, 3, 6, 12, 24, 36, 48, and 72 hours to mimic the residence time of particles in extracellular lung fluid . Phagolysosomal simulant fluid (PSF) buffered with 0.02 M potassium hydrogen phthalate was used to model dissolution in lung alveolar macrophages . This solvent consists of sodium (116.8 mM), chloride (114.2 mM), potassium (25.0 mM), glycine (6.0 mM), phosphate (1.0 mM), sulfate (0.5 mM), and calcium (0.2 mM). The pH of PSF remained at 4.5 ± 0.1 throughout experiments. Masses of dissolved tungsten were measured at 1, 4, 8, 12, 24, and 72 hours, and then twice weekly thereafter to 31 days to mimic the approximate lifespan of an alveolar macrophage . In pilot studies, alkylbenzyldimethylammonium chloride, added to artificial lung fluids to prevent mold growth, inhibited dissolution of some tungsten oxide powders and was omitted from the full-scale experiments. Rather, mold growth was prevented by using sterile labware and laboratory practices.
Experimental and quality control samples were analyzed using U.S. Occupational Safety and Health Administration Method 213: Tungsten and Cobalt in Workplace Atmospheres: inductively coupled plasma analysis . Analysis of dissolved tungsten was performed using inductively coupled plasma-atomic emission spectroscopy (ICP-AES) without sample digestion. The analytical limit of detection (LOD) for tungsten in SUF was 0.03 mg L-1 and the limit of quantification (LOQ) was 0.11 mg L-1. For PSF, the tungsten LOD was 0.08 μg L-1 and the LOQ was 0.27 μg L-1. Undissolved particulate in the dissolution chambers exposed to SUF and PSF were digested and masses of tungsten quantified using ICP-AES; the tungsten LOD was 0.1 μg sample-1 and the LOQ was 0.43 μg sample-1.
where is the mass fraction of material remaining, t is time (days), d0 is the average initial fiber diameter (μm) from SEM analysis, ρ is the measured fiber density (g/cm3), and k is the chemical dissolution rate constant [g/(cm2·day)]. Values of were plotted versus time and non-linear least squares regression models used to estimate the best fit line for the data. The slope value, b, for this line was used to calculate t1/2 (i.e., -0.693/b) and to estimate k (i.e., b/SSA).
Values of were plotted versus time; however, only the linear portion of the segmented regression, which corresponded to the longer-term dissolution phase was used to calculate dissolution parameters. The slope of the best fit line from the plotted data, b, was used to calculate t1/2 and k as noted above.
Analysis of variance F-statistics were used to identify overall differences in dissolution half-times and mean rate constants among materials. Tukey's test was used to identify differences between paired means.
Figure 1 illustrates the morphology of the tungsten oxide study powders. The W and Co powders were both clusters of spherical primary particles. In the as-received state, the WO3 and WO2.98 powders were large, compact, mostly cube-shaped particles. The WO2.81, WO2.66, and WO2.51 powders were mixtures of compact cube-shaped and fiber-shaped particles. Dispersed WO2.81 and WO2.51 both contained long, thin fibers and cube-shaped particles, whereas WO2.66 contained short, cylinder-shaped and cube-shaped particles.
Physical properties of study powders.
Density (g/cm 3 )
SSA (m 2 /g)
AM ± SD
AM ± SD
AM ± SD
7.2 ± 0.0
0.75 ± 0.03
36.2 ± 20.4
94 ± 53
7.0 ± 0.0
11.10 ± 0.76
37.5 ± 26.0
95 ± 66
7.1 ± 0.0
2.85 ± 0.02
0.3 ± 0.3
8.8 ± 5.6
1.7 ± 1.4
8.2 ± 0.0
1.50 ± 0.07
0.5 ± 0.1
6.3 ± 0.7
3.1 ± 0.3
7.7 ± 0.1
2.10 ± 0.02
0.5 ± 0.2
7.6 ± 3.0
3.0 ± 0.9
19.2 ± 0.1
0.68 ± 0.09
2.5 ± 1.9
11.1 ± 8.1
8.2 ± 0.1
7.30 ± 0.24
2.4 ± 1.7
6.8 ± 4.9
Tungsten oxide powder surfaces were composed of tungsten and oxygen with minor amounts of carbon, which is consistent with tungsten oxides. Measured oxygen content of the well-defined WO3 material was greater than 95% of that predicted from the formula weight. The measured oxygen contents of the WO2.98, WO2.81, WO2.66, and WO2.51 powders were 19 ± 3%, 19 ± 0%, 16 ± 1%, and 16 ± 4%, respectively, which are consistent with the masses expected from the average stoichiometries of the powder constituents. The oxygen content of the tungsten metal study powder was <0.3%. Levels of impurities in the tungsten oxide materials were either below analytical LODs or ≤0.001% by weight (Sb, Ba, Cr, Cu, Fe, Se, and V).
In general, tungsten dissolution from each study powder consisted of a single phase that was best described by a single negative exponential. For a few powder/solvent combinations, dissolution was biphasic, consisting of an initial rapid dissolution phase followed by a long-term dissolution phase; these data were best described by two negative exponentials. The fraction of material dissolved during the initial phase was low, usually less than 2% of the total, so reported dissolution rates refer only to the long-term phase (see Figure 2).
Artificial airway epithelial lining fluid
Long-term dissolution parameters (mean ± standard deviation) for tungsten-containing materials after immersion in artificial airway epithelial lining fluid (pH 7.4) for 72 hours
Mixture with Cobalt
t 1/2 (days)
k [g/(cm 2 ·day)]
t 1/2 (days)
k [g/(cm 2 day)]
t 1/2 (days)
k [g/(cm 2 ·day)]
4 ± 1
2.5 ± 0.3 × 10-5
0.9 × 10-5
79 ± 23
1.3 ± 0.4 × 10-6
1 ± 0
6.0 ± 1.2 × 10-6
1 ± 0
6.0 ± 2.3 × 10-6
10 ± 2
6.5 ± 1.6 × 10-7
11 ± 2
2.3 ± 0.3 × 10-6
13 ± 1
1.9 ± 0.1 × 10-6
71 ± 6
3.5 ± 0.3 × 10-7
56 ± 10
8.4 ± 1.7 × 10-7
41 ± 2
1.1 ± 0.1 × 10-6
72 ± 22
6.8 ± 1.8 × 10-7
81 ± 4
4.1 ± 0.2 × 10-7
50 ± 14
6.9 ± 1.7 × 10-7
89 ± 13
3.8 ± 0.6 × 10-7
19 ± 2
5.4 ± 0.5 × 10-6
For a given fiber-containing tungsten oxide powder, k values in SUF did not differ among the as-received, dispersed, and mixture states. Dissolution rates (k-values) for the isometric-shaped WO3 and WO2.98 powders did not differ between the as-received and dispersed states; however, in the presence of cobalt their rates were slower.
Artificial alveolar macrophage phagolysosomal fluid
Long-term dissolution parameters (mean ± standard deviation) for tungsten-containing materials after immersion in artificial lung alveolar macrophage phagolysosomal fluid (pH 4.5) for 31 days
Mixture with Cobalt
t 1/2 (days)
k [g/(cm 2 ·day)]
t 1/2 (days)
k [g/(cm 2 ·day)]
t 1/2 (days)
k [g/(cm 2 ·day)]
9893 ± 2549
9.8 ± 2.9 × 10-9
21541 ± 1890
4.3 ± 0.4 × 10-9
8052 ± 2458
1.1 ± 0.4 × 10-8
656 ± 154
9.9 ± 2.6 × 10-9
929 ± 45
6.8 ± 0.3 × 10-9
655 ± 72
9.6 ± 1.0 × 10-9
2218 ± 84
1.1 ± 0.0 × 10-8
2207 ± 144
1.1 ± 0.1 × 10-8
2084 ± 102
1.2 ± 0.1 × 10-8
181 ± 7
2.6 ± 0.1 × 10-7
214 ± 6
2.2 ± 0.1 × 10-7
218 ± 17
2.1 ± 0.2 × 10-7
2455 ± 422
1.4 ± 0.2 × 10-8
2915 ± 414
1.1 ± 0.2 × 10-8
1343 ± 252
2.5 ± 0.5 × 10-8
97 ± 17
1.1 ± 0.2 × 10-6
For a given tungsten oxide powder, values of t1/2 did not differ among states in PSF with the exception of a longer half-time for WO3 in the dispersed state than in the as-received and mixed states. For a given powder, its k-values did not differ among states in PSF.
The rate at which materials are cleared from the respiratory tract depends upon the location in which the material deposits, the physicochemical form of the material, and the time since deposition . In the present study, dissolution was evaluated for tungsten oxides having varying physicochemical properties in two artificial lung environments, one mimicking the fluid lining the airways (i.e., SUF) and the other mimicking the fluid contained in alveolar macrophage phagolysosomes (i.e., PSF). Clear differences in dissolution behavior were observed among and within tungsten oxide powders in SUF and PSF. Such differences are important for understanding the relative persistence of tungsten oxides in the lung.
Mechanical clearance half-times for durable particles that deposit in the conducting airways are approximately 8 hours (bronchioles to bronchi), 100 minutes (bronchi to extrathoracic airways), and 10 minutes (extrathoracic airways to the gastrointestinal tract) via the mucociliary escalator . In SUF, the as-received and dispersed WO3 and WO2.98 had the fastest dissolution rates among all the studied powders, though the presence of cobalt slowed dissolution of these materials. Based on the measured surface area and dissolution rates, the amounts of material dissolved from WO3 in each of the above-listed clearance half-times would be 6% (8 hours), 1% (100 minutes), and 0.1% (10 minutes), whereas the amounts of material dissolved from WO2.98 would be 20% (8 hours), 5% (100 minutes), and 0.5% (10 minutes). Thus, clearance of these materials from the conducting airways would include both mechanical action and dissolution. The WO3 and WO2.98 powders are crystallographically similar materials and the high solubility of these materials supports the results of Aamodt , who observed that approximately one-third of an inhaled WO3 particle dose enters systemic circulation. Interestingly, in all states evaluated, WO2.66 dissolved faster in SUF than the other fiber-containing samples which may be due to its higher mass fraction of isometric-shaped particles (Table 1). However, in all states evaluated, the fiber-containing tungsten oxide powders dissolved more slowly than the isometric-shaped materials. This suggests that clearance of fiber-containing tungsten oxide powders from the conducting airways would be dominated by mechanical mechanisms with little (<1%) dissolving during a single clearance half-time.
The orientation-averaged Dae and aspect ratios of the WO2.81, WO2.66, and WO2.51 fibers indicate that they were respirable, with high probability of deposition in the non-ciliated alveolar region of the lung (Table 1). The dimensions of fibers in these bulk tungsten oxide powders are consistent with previous reports that airborne tungsten oxide fibers in workplace atmospheres had respirable or thoracic size [1, 4, 7]. Within 24 hours, 90% of particles deposited in the alveolar region of the lung are associated with macrophage cells . The lengths of the WO2.81, WO2.66, and WO2.51 fibers ranged from 6 to 9 μm, which is sufficient to inhibit their clearance from alveoli by macrophages [8, 9]. As such, dissolution in macrophage phagolysosomal fluid is likely to play an important role in the clearance of relatively insoluble materials such as TBO fibers that deposit in the alveolar region of the lung.
Often, rate of metal dissolution increases as solvent pH decreases . However, in the current study, dissolution rates of each tungsten oxide material were up to four orders of magnitude slower in PSF than in SUF, indicating potential for long-term retention of tungsten oxides that deposit in the alveolar region of the lung. With regards to dissolution in PSF, the fiber-containing WO2.81, WO2.66, and WO2.51 powders dissolved more slowly in the as-received state than tungsten metal powder, indicating potential for longer persistence in the alveoli. In the dispersed and mixed states, WO2.66 powder, but not WO2.81 or WO2.51 powder, dissolved more rapidly than the other tungsten oxide powders. Overall, these results suggest that fiber-containing tungsten oxides that deposit in the alveolar region of the lung would have similar biopersistence to isometric-shaped WO3 and WO2.98, but would be more biopersistent than tungsten metal.
The toxicity of tungsten compounds provides limited clues as to potential adverse effects from inhalation of tungsten oxide fibers. Workers that grind cemented tungsten carbides are exposed to mixed dusts containing tungsten, which persists in the alveoli for years . Workers in the cemented tungsten carbide industry are exposed to several tungsten compounds which have a range of solubility in the body . WO3 was reported to cause mild pulmonary fibrosis in rats , though this effect was not confirmed in another study . Laboratory-prepared TBO materials can generate free radicals at rates higher than asbestos in vitro, which could contribute to development of pulmonary fibrosis  though it is unknown whether this reaction occurs in vivo. Tungsten oxide fibers can be present in workplaces that use cobalt  and cobalt is known to enhance the toxicity of some tungsten compounds by generating free radicals . In the current study, the dissolution rates of each fiber-containing tungsten oxide powder did not differ among the as-received, dispersed, and cobalt mixture states. Hence, whether inhaled as tungsten oxide or tungsten oxide/cobalt mixtures, these powders will persist in the alveoli and present opportunity for generation of free radicals. Shvedova et al.  reported that dispersed SWCNT were associated with diffuse interstitial fibrosis and aggregated SWCNT induced granulomas in mouse lung. Particle dispersion may variably influence in vivo biopersistence in relation to the capacity of macrophages to engulf agglomerated versus individual fibers. In the current study, there were no differences in dissolution rates between as-received and dispersed tungsten oxide fibers. The potential for adverse health effects due to long-term persistence of tungsten oxide fibers in the alveolar region of the lung remains poorly understood.
Finally, it is interesting to note that historically, an early method for producing non-sag tungsten metal wire involved reduction of WO3. Later, in the 1970 s, industrial producers began to use TBOs because these materials have higher surface area and therefore are better at absorbing potassium ions, which are important for product performance . While the TBOs are better at absorbing potassium ions, WO3 can be made to have the same surface area as TBOs and high-quality wire can be produced using WO3 . The WO3 material evaluated in this study had a mean equivalent Dae of approximately 100 μm, much larger than the Dae of the three fiber-containing TBOs. Thus, when inhaled, the WO3 material evaluated in this study would be more likely to deposit in the more rapidly cleared upper conducting airways and less likely to be deposited in the more slowly cleared alveolar regions of the lung. Also, the WO3 material evaluated in this study was more soluble than the three fiber-containing TBOs evaluated in this study. In light of the measured particle physical characteristics and observed dissolution data, in vivo studies to evaluate toxicity of TBOs relative to WO3 powder may be worthwhile to determine whether substitution of WO3 for TBOs is appropriate.
The current study focused on the durability of three fiber-containing tungsten oxide powders in artificial lung fluids and compared their dissolution behavior to tungsten metal and two isometric-shaped tungsten oxide powders. Dissolution rates of tungsten compounds were one to four orders of magnitude slower in PSF compared to SUF. The physical state of the tungsten oxides (as-received versus dispersed) had no effect on dissolution behavior in either SUF or PSF. The presence of cobalt did not influence dissolution of the fiber-containing tungsten oxide powders; however, dissolution rates of WO3 and WO2.98 in SUF were slowed by cobalt. Compared to tungsten metal powder, a known mild pulmonary irritant, dissolution rates of fiber-containing WO2.66 and WO2.51 powders were slower in SUF and dissolution rates of all three fiber-containing TBO powders were slower in PSF. The slow dissolution of tungsten oxide fibers, coupled with existing toxicology information on tungsten compounds, suggests additional research is needed to fully understand the hazard potential of these fibers.
The author thanks M. Duling, R. Lawrence, D. Sbarra, and B. Tift for their assistance and M.D. Hoover and M.A. Virji for helpful discussions and critical review of this manuscript. The findings and conclusions in this report are those of the author and do not necessarily represent the views of the National Institute for Occupational Safety and Health.
This work was supported by the National Toxicology Program through interagency agreement Y1-ES-9045-15 with the National Institute for Occupational Safety and Health. The funding source had no role in the study design; data collection, analysis and interpretation; in the writing of the report; or in the decision to submit this paper for publication.
- McKernan JL, Toraason MA, Fernback JE, Petersen MR: Presence of tungsten-containing fibers in tungsten refining and manufacturing processes. Ann Occup Hyg 2009, 53:215–224.View ArticlePubMedPubMed Central
- Lunk H-J, Ziemer B, Salmen M, Heidemann D: What is behind "tungsten blue oxides"? Refractory Metals Hard Materials 1993, 12:17–26.View Article
- Lassner E, Schubert W-D: Tungsten blue oxide. Int J Refractory Metals Hard Materials 1995, 13:111–117.View Article
- Sahle W: Possible role of tungsten oxide whiskers in hard-metal pneumoconiosis. Chest 1992, 102:1310.View ArticlePubMed
- Sahle W, Laszlo I, Krantz S, Christensson B: Airborne tungsten oxide whiskers in a hard-metal industry. Preliminary findings. Ann Occup Hyg 1994, 38:37–44.View Article
- Sahle W, Krantz S, Christensson B, Laszlo I: Preliminary data on hard metal workers exposure to tungsten oxide fibers. Sci Total Environ 1996, 191:153–167.View ArticlePubMed
- McKernan JL, Toraason MA, Fernback JE: Presence of airborne fibers in tungsten refining and manufacturing processes: Preliminary characterization. J Occup Environ Hyg 2008, 5:463–474.View ArticlePubMed
- Davis JMG: The role of clearance and dissolution in determining the durability and biopersistance of mineral fibers. Environ Health Perspect 1994,102(Suppl 5):113–117.View ArticlePubMedPubMed Central
- Oberdörster G: Toxicokinetics and effects of fibrous and nonfibrous particles. Inhal Toxicol 2002, 14:29–56.View ArticlePubMed
- Keith LS, Moffett DB, Rosemond ZA, Wohlers DW: ATSDR evaluation of health effects of tungsten and relevance to public health. Toxicol Indust Health 2007, 23:347–387.View Article
- Wang FS, Liu LF, Chen NM, Li YR: A study on cellular reactions and fibrogenic effects of mineral dusts. Biomed Environ Sci 1994, 7:116–121.PubMed
- Aamodt RL: Inhalation of 181-W labeled tungstic oxide by six beagle dogs. Health Phys 1975, 26:733–742.View Article
- Rüttner JR, Spycher MA, Stolkin I: Inorganic particulates in pneumoconiotic lungs of hard metal grinders. Br J Indust Med 1987, 44:657–660.
- Kraus T, Schramel P, Schaller KH, Zöbelein P, Weber A, Angerer J: Exposure assessment in the hard metal manufacturing industry with special regard to tungsten and its compounds. Occup Environ Med 2001, 58:631–634.View ArticlePubMedPubMed Central
- Leanderson P, Sahle W: Formation of hydroxyl radicals and toxicity of tungsten oxide fibres. Toxicol In Vitro 1995, 9:175–183.View ArticlePubMed
- Stefaniak AB, Day GA, Harvey CJ, Leonard SS, Schwegler-Berry DE, Chipera SJ, Sahakian NM, Chisholm WP: Characteristics of dusts encountered during the production of cemented tungsten carbides. Ind Health 2007, 45:793–803.View ArticlePubMed
- Shvedova AA, Kisin ER, Mercer R, Murray AR, Johnson VJ, Potapovich AI, Tyurina YY, Gorelik O, Arepalli S, Schwegler-Berry D, Hubbs AF, Antonini J, Evans DE, Ku BK, Ramsey D, Maynard A, Kagan VE, Castranova V, Baron P: Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice. Am J Physiol Lung Cell Mol Physiol 2005, 289:L698-L708.View ArticlePubMed
- Lison D, Lauwerys R: The interaction of cobalt metal with different carbides and other mineral particles on mouse peritoneal macrophages. Toxicol In Vitro 1995, 9:341–347.View ArticlePubMed
- International Organization for Standardization: ISO 14887:2000: Sample preparation -- Dispersing procedures for powders in liquids. ISO, Geneva, Switzerland; 2000.
- ASTM International: ASTM B922–02: Standard Test Method for Metal Powder Specific Surface Area by Physical Adsorption. ASTM International, West Consohocken, PA; 2002.
- Vaughan NP: The aerodynamic behaviour of cylindrical and spheroidal particles when settling under gravity. J Aerosol Sci 1986, 17:53–65.View Article
- Hinds WC: Aerosol Technology: Properties, behavior, and measurement of airborne particles. New York: John Wiley and Sons; 1999.
- ASTM International: ASTM D5291- 02: Standard Test Methods for Instrumental Determination of Carbon, Hydrogen, and Nitrogen in Petroleum Products and Lubricants. ASTM International, West Conshohocken, PA; 2002.
- ASTM International: ASTM D5373–08: Standard Test Methods for Instrumental Determination of Carbon, Hydrogen, and Nitrogen in Laboratory Samples of Coal. ASTM International, West Conshohocken, PA; 2008.
- ASTM International: ASTM D4239–08 Standard Test Methods for Sulfur in the Analysis Sample of Coal and Coke Using High-Temperature Tube Furnace Combustion Methods ASTM International. West Conshohocken, PA; 2008.
- National Institute for Occupational Safety and Health: NIOSH Manual of Analytical Methods (NMAM®). 4th edition. Edited by: Schlecht PC, O'Connor PF. DHHS (NIOSH) Publication 94–113 (August, 1994); 1994. 1st Supplement Publication 96–135, 2nd Supplement Publication 98–119, 3rd Supplement 2003–154
- Kanapilly GM, Raabe OG, Goh CH, Chimenti RA: Measurement of in vitro dissolution of aerosol particles for comparison to in vivo dissolution in the lower respiratory tract after inhalation. Health Phys 1973, 24:497–507.View ArticlePubMed
- Finch GL, Mewhinney JA, Eidson AF, Hoover MD, Rothenberg SJ: In vitro dissolution characteristics of beryllium oxide and beryllium metal aerosols. J Aerosol Sci 1988, 19:333–342.View Article
- Lehnert BE, PE Morrow: Association of 59Iron oxide with alveolar macrophages during alveolar clearance. Exp Lung Res 1985, 9:1–16.View ArticlePubMed
- Stefaniak AB, Guilmette RA, Day GA, Hoover MD, Breysse PN, Scripsick RC: Characterization of phagolysosomal fluid for study of beryllium aerosol particle dissolution. Toxicol In Vitro 2005, 19:123–134.View ArticlePubMed
- Bowden DH: Cell turnover in the lung. Am Rev Respir Dis 1983,128(Suppl 2):S46-S48.PubMed
- Occupational Safety and Health Administration: OSHA Sampling and Analytical Methods. Salt Lake City, UT; 1994.
- Mercer TT: On the role of particle size in dissolution of lung burdens. Health Phys 1967, 13:1211–1221.View ArticlePubMed
- Potter RM, Mattson SM: Glass fiber dissolution in a physiological saline solution. Glastech Ber 1991, 64:16–28.
- Stefaniak AB, Virji MA, Day GA: Release of beryllium from beryllium-containing materials in artificial skin surface film liquids. Ann Occup Hyg 2010, in press.
- Stefaniak AB, Harvey CJ, Bukowski VC, Leonard SS: Generation of free radicals by pre- and post-sintered cemented carbide particles. J Occup Environ Health 2010, 7:23–34.
- International Commission on Radiological Protection: Human Respiratory Tract Model for Radiological Protection, ICRP Publication 66. 1994. Exeter
- Collier CG, Pearce MJ, Hodgson A, Ball A: Factors affecting the in vitro dissolution of cobalt oxide. Environ Health Perspect 1992, 97:109–113.View ArticlePubMedPubMed Central
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.